RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bionano Genomics Stock

Bionano Genomics Liabilities 2025

Bionano Genomics Liabilities

41.29 M USD

Ticker

BNGO

ISIN

US09075F4046

WKN

A2JRLZ

In 2025, Bionano Genomics's total liabilities amounted to 41.29 M USD, a -65.08% difference from the 118.25 M USD total liabilities in the previous year.

Bionano Genomics Aktienanalyse

What does Bionano Genomics do?

Bionano Genomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bionano Genomics's Liabilities

Bionano Genomics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bionano Genomics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bionano Genomics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bionano Genomics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bionano Genomics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bionano Genomics stock

What is the level of liabilities of Bionano Genomics this year?

Bionano Genomics has a debt balance of 41.29 M USD this year.

What were the liabilities of Bionano Genomics compared to the previous year?

The liabilities of Bionano Genomics have increased by -65.08% dropped compared to the previous year.

What are the consequences of high debt for investors of Bionano Genomics?

High liabilities can pose a risk for investors of Bionano Genomics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bionano Genomics?

Low liabilities mean that Bionano Genomics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bionano Genomics affect the company?

An increase in liabilities of Bionano Genomics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bionano Genomics affect the company?

A decrease in the liabilities of Bionano Genomics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bionano Genomics?

Some factors that can influence the liabilities of Bionano Genomics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bionano Genomics so important for investors?

The liabilities of Bionano Genomics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bionano Genomics take to modify the liabilities?

To change its liabilities, Bionano Genomics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bionano Genomics pay?

Over the past 12 months, Bionano Genomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionano Genomics is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionano Genomics?

The current dividend yield of Bionano Genomics is .

When does Bionano Genomics pay dividends?

Bionano Genomics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionano Genomics?

Bionano Genomics paid dividends every year for the past 0 years.

What is the dividend of Bionano Genomics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionano Genomics located?

Bionano Genomics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionano Genomics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionano Genomics from 10/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2025.

When did Bionano Genomics pay the last dividend?

The last dividend was paid out on 10/3/2025.

What was the dividend of Bionano Genomics in the year 2024?

In the year 2024, Bionano Genomics distributed 0 USD as dividends.

In which currency does Bionano Genomics pay out the dividend?

The dividends of Bionano Genomics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bionano Genomics

Our stock analysis for Bionano Genomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionano Genomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.